Ajay Bansal

Directeur Financier/CFO chez UROVANT SCIENCES LTD.

Profil

Ajay Bansal currently works at Urovant Sciences Ltd., as Chief Financial Officer & SVP-Business Development from 2019.
Mr. Bansal also formerly worked at Capital One Financial Corp., as Director-Operations Analysis from 2002 to 2003, Nektar Therapeutics, as Chief Financial Officer from 2003 to 2006, Lexicon Pharmaceuticals, Inc., as CFO & Executive VP-Business Development in 2010, Tercica, Inc., as CFO & Executive VP-Business Development from 2007 to 2008, Onconova Therapeutics, Inc., as Chief Financial Officer & Secretary from 2014 to 2016, ViewRay Technologies, Inc., as Chief Financial & Accounting Officer, Complete Genomics, Inc., as Chief Financial Officer from 2012 to 2013, ViewRay, Inc., as Chief Financial & Accounting Officer from 2016 to 2019, McKinsey & Co., Inc., as Engagement Manager from 1988 to 1991, Mehta Partners LLC, as Partner from 1998 to 2002, ZS Associates, Inc., as Consultant from 1985 to 1987, and Novartis Pharmaceuticals Corp., as Principal.
Mr. Bansal received his graduate degree in 1985 and Masters Business Admin degree in 1985 from Northwestern University and undergraduate degree in 1984 from Indian Institute of Technology New Delhi.

Postes actifs de Ajay Bansal

Sociétés	Poste	Début
UROVANT SCIENCES LTD.	Directeur Financier/CFO	28/10/2019

Anciens postes connus de Ajay Bansal

Sociétés	Poste	Fin
VIEWRAY SYSTEMS, INC.	Directeur Financier/CFO	30/09/2019
TRAWS PHARMA, INC.	Directeur Financier/CFO	12/02/2016
COMPLETE GENOMICS, INC.	Directeur Financier/CFO	01/03/2013
LEXICON PHARMACEUTICALS, INC.	Directeur Financier/CFO	08/01/2010
Tercica, Inc.	Directeur Financier/CFO	01/10/2008